Partner Keir Dougall will speak on “Resolving Conflicts of Interest and Protecting Privilege for Representing Companies and Individuals Under Investigation” at 4:30 p.m. on Wednesday, April 29.

Topics of this conference include:

  • How to prepare for increased scrutiny
  • How pharma and life sciences industries are uniquely affected by the FCPA
  • Solutions for minimizing the risk of violations and enhancing compliance efforts